Chromosome fragile sites in mentally retarded males: Increased incidence with seizures and diphenylhydantoin therapy

Annals of Clinical and Laboratory Science

Volumn 28, Issue 5, 1998, Pages 293-299

  Hodges, Kurt B ^a   Larson, Richard S ^b   Butler, Merlin G ^c  

^a Lewis Gale Clinic   (United States)

^b UNIVERSITY OF NEW MEXICO HOSPITAL   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 10Q; CHROMOSOME 12Q; CHROMOSOME 16Q; CHROMOSOME FRAGILE SITE; CYTOGENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SEIZURE SUSCEPTIBILITY;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CONTINENTAL POPULATION GROUPS; CULTURE MEDIA; HUMANS; LYMPHOCYTES; MALE; MENTAL RETARDATION; MIDDLE AGED; PHENYTOIN; SEIZURES;

EID: 0031684591     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hecht F, Ramesh KH, Lockwood DH. A guide to fragile sites on human chromosomes. Cancer Genetics Cytogenetics 1990;44:37-45.
2. Kitsiou-Tzeli S, Galla-Voumvouraki A, Tsezou A, et al. Cytogenetic studies in children on long-term anticonvulsant therapy. Acta Pædiat 1994;83:672-3.
3. Bartsch HD. Cytogenetic testing in antiepileptic drugs in human patients. Mutation Res 1975;29: 279-81.
4. Goyle S, Maurya AK, Rout UK, et al. Mutagenic risk in epileptic patients before and after anticonvulsant therapy. Epilepsia 1987;28:81-6.
5. Habedank M, Esser KJ, Brull D, et al. Increased sister chromatid exchanges in epileptic children during long-term therapy with phenytoin. Human Genet 1982;61:71-2.
6. Sardas S, Ada M, Karakaya AE, et al. Sister-chromatid exchange in epileptic patients on anticonvulsant therapy. Mutation Res 1994;313:21-4.
7. Musumeci SA. The meaning of seizures, paroxysmal activity and hypereactivity in subjects with Fragile X syndrome. 1992 International Fragile X Conference Proceedings. Snowmass, Co., June 16-20, 1992.
8. Butler MG, Allen AG, Haynes JL, et al. Chromosome lesions which could be interpreted as "fragile sites" on the distal end of Xq. Amer J Human Genet 1990;37: 250-3.
9. DeLisi LE, Ross AL, White BJ, et al. Cytogenetic and other chromosomal abnormalities. Schizophrenia Res 1988;1:277-81.
10. Garafola G, Ragusa RM, Barletta E, et al. Schizophrenia and chromosomal fragile sites. Amer J Psychiatry 1992;149:1116.
11. Freund LS, Reiss AL, Hagerman R, et al. Chromosome fragility and psychopathology in obligate female carriers of the fragile X-chromosome. Arch Gen Psychiatry 1992;49:54-60.
12. Butler MG. No significant relationship between age and frequency of chromosome lesions in mentally retarded individuals with or without the fragile X syndrome. Human Genet 1990;84:216-7.
13. Butler MG, Jenkins BB. Sister chromatid exchange analysis in the Prader-Labhart-Willi syndrome. Amer J Med Genet 1987;28:821-7.
14. Butler MG, Jenkins BB. Analysis of chromosome breakage in the Prader-Labhart-Willi syndrome. Amer J Med Genet 1989;2:514-9.
15. Telvi L, Leboyer M, Chirou C, et al. Is Rett syndrome a chromosome breakage syndrome? Amer J Med Genet 1994;5:602-5.
16. Geriche GS, Simonie I, Cloete E, et al. Increased expression of aphidocolin-induced common fragile sites in Tourette syndrome. Amer J Med Genet 1996; 67:25-30.
17. Gebhart E. Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing. Human Genet 1981;58:235-54.
18. Esser KJ, Kotlarek F, Habedank M, et al. Chromosomal investigations in epileptic children during long-term therapy with phenytoin or primidone. Human Genet 1981;56:345-8.